Callitas Health Inc buy Quitte
Start price
30.06.17
/
50%
€0.41
Target price
01.01.18
€0.80
Performance (%)
-63.41%
End price
01.01.18
€0.15
Summary
This prediction ended on 01.01.18 with a price of €0.15. Massive losses of -63.41% were the result for the BUY prediction by Quitte. Quitte has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Callitas Health Inc | - | - | - | - |
iShares Core DAX® | 1.887% | 1.967% | 17.000% | 18.227% |
iShares Nasdaq 100 | 2.316% | -1.227% | 22.986% | 35.321% |
iShares Nikkei 225® | 1.134% | 0.390% | 9.520% | -0.898% |
iShares S&P 500 | 1.821% | 0.790% | 22.957% | 39.161% |
Comments by Quitte for this prediction
In the thread Callitas Health Inc diskutieren
Cash- Zunahme mit Abnehm-Produkt
einfach mal sehen, was die Trommelei bewirkt ......
DICKER VERSUCHSBALLON !! Hoffentlich lässt er nicht gleich wieder Luft ab ;-)
https://www.irw-press.com/de/news/neue-900-aktienchance-verzehnfacher-mit-dieser-biotech-aktie-spektakulaere-joint-ventures-in-wenigen-tagen-2-produkte-mit-fda-zulassung-besser-als-paion-und-evotec-top-biotech-aktienempfehlung-m-pharmaceutical-inc-ac-research_40237.html?isin=CA55346E2050
(Laufzeit überschritten)